June 19 (Reuters) - Amgen Inc AMGN.O :
* HEALTH CANADA APPROVES AMGEN'S REPATHA® (EVOLOCUMAB) TO REDUCE RISK OF CARDIOVASCULAR EVENTS IN ADULTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
June 19 (Reuters) - Amgen Inc AMGN.O :
* HEALTH CANADA APPROVES AMGEN'S REPATHA® (EVOLOCUMAB) TO REDUCE RISK OF CARDIOVASCULAR EVENTS IN ADULTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE